What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Suresh T. Chari mainly focuses on Internal medicine, Autoimmune pancreatitis, Pathology, Pancreatitis and Pancreatic cancer.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Diabetes mellitus.
The study incorporates disciplines such as Inflammatory bowel disease, Immunology, Pancreatic mass, Obstructive jaundice and Serology in addition to Autoimmune pancreatitis.
Pathology and Pancreas are frequently intertwined in his study.
His Pancreatitis study combines topics in areas such as Epidemiology, Jaundice, Pathogenesis, Acute pancreatitis and Pancreatic disease.
His studies examine the connections between Pancreatic cancer and genetics, as well as such issues in Pancreatic duct, with regards to Carcinoma, Malignancy, Histology and Radiology.
His most cited work include:
- International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. (1642 citations)
- International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas (1629 citations)
- Consensus statement on the pathology of IgG4-related disease (1484 citations)
What are the main themes of his work throughout his whole career to date?
Suresh T. Chari mostly deals with Internal medicine, Gastroenterology, Pancreatic cancer, Pancreatitis and Autoimmune pancreatitis.
Suresh T. Chari works mostly in the field of Internal medicine, limiting it down to concerns involving Diabetes mellitus and, occasionally, Body mass index.
His study ties his expertise on Primary sclerosing cholangitis together with the subject of Gastroenterology.
Suresh T. Chari has researched Pancreatic cancer in several fields, including Adenocarcinoma, Cancer research, Early detection and Risk factor.
His study brings together the fields of Pancreatic disease and Pancreatitis.
Suresh T. Chari's looking at Autoimmune pancreatitis as part of his Pathology and Disease and Autoimmune pancreatitis study.
He most often published in these fields:
- Internal medicine (49.42%)
- Gastroenterology (28.88%)
- Pancreatic cancer (26.54%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (49.42%)
- Pancreatic cancer (26.54%)
- Gastroenterology (28.88%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Pancreatic cancer, Gastroenterology, Diabetes mellitus and Oncology.
His research ties Endocrinology and Internal medicine together.
His work focuses on many connections between Pancreatic cancer and other disciplines, such as Pancreas, that overlap with his field of interest in Radiology and Convolutional neural network.
His Gastroenterology research integrates issues from Asymptomatic and Intraductal papillary mucinous neoplasm.
His study in Pancreatitis focuses on Autoimmune pancreatitis in particular.
His work is dedicated to discovering how Autoimmune pancreatitis, Rituximab are connected with IgG4-related disease and other disciplines.
Between 2016 and 2021, his most popular works were:
- Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer. (120 citations)
- Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis (119 citations)
- The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease (116 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Suresh T. Chari mainly investigates Internal medicine, Pancreatic cancer, Pancreatitis, Diabetes mellitus and Gastroenterology.
His work carried out in the field of Pancreatic cancer brings together such families of science as Pancreatic cysts, Prospective cohort study, Cohort study and Oncology.
His Pancreatitis research is multidisciplinary, relying on both Stage, Acute pancreatitis, Hepatitis and Pathology.
His research integrates issues of Relapse rate, Therapeutic strategy and Steroid therapy in his study of Pathology.
His work on Type 2 diabetes, Adipokine and Diabetes obesity as part of general Diabetes mellitus research is frequently linked to High-density lipoprotein, thereby connecting diverse disciplines of science.
His work in Gastroenterology addresses subjects such as Intraductal papillary mucinous neoplasm, which are connected to disciplines such as Pancreatic duct, Dysplasia, Surgical strategy and General surgery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
